Avai Bio annual revenue
2020
2023
2024
2025
2026
Avai Bio reported $0 in revenue for fiscal 2026.
View full Avai Bio company overview| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $0 | $0 | — |
| 2025 | 2025-03-31 | $0 | $0 | — |
| 2024 | 2024-03-31 | $0 | −$276,324 | −100.00% |
| 2023 | 2023-03-31 | $276,324 | — | — |
| 2020 | 2020-03-31 | $1.4M | — | — |
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q1 2027 | 2026-06-30 | $0 | $0 | — |
| Q4 2026 | 2026-03-31 | $0 | $0 | — |
| Q3 2026 | 2025-12-31 | $0 | $0 | — |
| Q2 2026 | 2025-09-30 | $0 | — | — |
| Q1 2026 | 2025-06-30 | $0 | — | — |
| Q4 2025 | 2025-03-31 | $0 | — | — |
| Q3 2025 | 2024-12-31 | $0 | — | — |
| Q3 2021 | 2020-12-31 | $309,564 | — | — |
| Q2 2021 | 2020-09-30 | $709,206 | — | — |
| Q1 2021 | 2020-06-30 | $598,426 | — | — |
Avai Bio's latest reported quarter, Q1 2027, generated $0 in revenue.
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Avai Bio source filings ↗